Order Article Reprints

Zerr I, Villar-Piqué A, Schmitz VE, Poleggi A, Pocchiari M, Sánchez-Valle R, Calero M, Calero O, Baldeiras I, Santana I, et al. Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients. Biomolecules. 2019; 9(12):800. https://doi.org/10.3390/biom9120800

Zerr, Inga, Anna Villar-Piqué, Vanda Edit Schmitz, Anna Poleggi, Maurizio Pocchiari, Raquel Sánchez-Valle, Miguel Calero, Olga Calero, Inês Baldeiras, Isabel Santana, and et al. 2019. "Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients" Biomolecules 9, no. 12: 800. https://doi.org/10.3390/biom9120800

Zerr, I., Villar-Piqué, A., Schmitz, V. E., Poleggi, A., Pocchiari, M., Sánchez-Valle, R., Calero, M., Calero, O., Baldeiras, I., Santana, I., Kovacs, G. G., Llorens, F., & Schmitz, M. (2019). Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients. Biomolecules, 9(12), 800. https://doi.org/10.3390/biom9120800